A selective estrogen receptor modulator, tamoxifen, and membrane fluidity of erythrocytes in normotensive and hypertensive postmenopausal women: An electron paramagnetic resonance investigation

American Journal of Hypertension

Volumn 18, Issue 8, 2005, Pages 1067-1076

  Tsuda, Kazushi ^a   Nishio, Ichiro ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Electron paramagnetic resonance; Erythrocytes; Membrane fluidity; Postmenopausal women; Selective estrogen receptor modulator; Tamoxifen

Indexed keywords

8 BROMO CYCLIC GMP; ARGININE; ARGININE DERIVATIVE; CYCLIC GMP DERIVATIVE; ESTROGEN RECEPTOR; FULVESTRANT; HORMONE RECEPTOR BLOCKING AGENT; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STEARIC ACID DERIVATIVE; TAMOXIFEN;

AGED; ARTICLE; CELL MEMBRANE FLUIDITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ELECTRON SPIN RESONANCE; ERYTHROCYTE MEMBRANE; FEMALE; HUMAN; HUMAN CELL; HYPERTENSION; POSTMENOPAUSE; PRIORITY JOURNAL; SPIN LABELING; VISCOSITY;

AGED; ANALYSIS OF VARIANCE; ARGININE; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ELECTRON SPIN RESONANCE SPECTROSCOPY; ENZYME INHIBITORS; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; HYPERTENSION; MEMBRANE FLUIDITY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; POSTMENOPAUSE; S-NITROSO-N-ACETYLPENICILLAMINE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 23744438080     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2005.02.009     Document Type: Article

References (33)

1. M.J. Stampfer, G.A. Golditz, W.C. Willett, J.E. Manson, B. Rosner, F.E. Speizer, C.H. Hennekens Postmenopausal estrogen therapy and cardiovascular disease N Engl J Med 325 1991 756 762
2. S. Oparil Hormones and vasoprotection Hypertension 33 1999 170 176
3. Writing Group for the WHI Investigators Risk and benefits of estrogen plus progestin in healthy postmenopausal women from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
4. L.E. Rutqvist, A. Mattsson Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen the Stockholm Breast Cancer Study Group J Natl Cancer Inst 85 1993 1398 1406
5. C.C. McDonald, F.E. Alexander, B.W. Whyte, A.P. Forrest, H.J. Stewart Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomized trial the Scottish Cancer Trials Breast Group BMJ 311 1995 977 980
6. T. Simon, P. Boutouyrie, J.M. Simon, B. Laloux, C. Tournigand, A.I. Tropeano, S. Laurent, P. Jaillon Influence of tamoxifen on carotid intima-media thickness in postmenopausal women Circulation 106 2002 2925 2929
7. K.M. Dhandapani, D.W. Brann Protective effects of estrogen and selective estrogen receptor modulators in the brain Biol Reprod 67 2002 1379 1385
8. H.K. Kimelberg, Y. Jin, C. Charniga, P.J. Feustel Neuroprotective activity of tamoxifen in permanent focal ischemia J Neurosurg 99 2003 138 142
9. E. Thorin, M. Pham-Dang, R. Clement, I. Mercier, A. Calderone Hyper-reactivity of cerebral arteries from ovariectomized rats therapeutic benefit of tamoxifen Br J Pharmacol 140 2003 1187 1192
10. Y. Yamori, Y. Nara, R. Horie, A. Ooshima Abnormal membrane characteristics of erythrocytes in rat models and men with predisposition to stroke Clin Exp Hypertens A2 1980 1009 1021
11. G. Zerbini, G. Ceolotto, C. Gaboury, L. Mos, A.C. Pessina, M. Canessa, A. Semplicini Sodium-lithium countertransport has low affinity for sodium in hyperinsulinemic hypertensive subjects Hypertension 25 1995 986 993
12. K. Tsuda, I. Nishio Membrane fluidity and hypertension Am J Hypertens 16 2003 259 261
13. R.A. Cooper Abnormalities of cell-membrane fluidity in the pathogenesis of disease N Engl J Med 297 1977 371 377
14. J. Zicha, J. Kunes, M.A. Devynck Abnormalities of membrane function and lipid metabolism in hypertension Am J Hypertens 12 1999 315 331
15. +-ATPase activity Nitric Oxide 4 2000 333 342
16. K. Tsuda, K. Kimura, I. Nishio, Y. Masuyama Nitric oxide improves membrane fluidity of erythrocytes in essential hypertension - an electron paramagnetic resonance investigation Biochem Biophys Res Commus 275 2000 946 954
17. K. Tsuda, Y. Kinoshita, K. Kimura, I. Nishio, Y. Masuyama Electron paramagnetic resonance investigation on modulatory effect of 17β-estradiol on membrane fluidity of erythrocytes in postmenopausal women Arterioscler Thromb Vasc Biol 21 2001 1306 1312
18. B. Sato, K. Nishikida, L.T. Samuels, F.H. Tyler Electron spin resonance studies of erythrocytes from patients with Duchenne muscular dystrophy J Clin Invest 61 1978 251 259
19. K. Tsuda, H. Iwahashi, Y. Minatogawa, I. Nishio, R. Kido, Y. Masuyama Electron spin resonance studies of erythrocytes from spontaneously hypertensive rats and humans with essential hypertension Hypertension 9 Suppl III 1987 III-19 III-24
20. H. Wiseman, P. Quinn, B. Halliwell Tamoxifen and related compounds decrease membrane fluidity in liposomes. Mechanism for the antioxidant action of tamoxifen and relevance to its anticancer and cardioprotective action FEBS Lett 330 1993 53 56
21. R. Clarke, H.W. van den Berg, R.F. Murphy Reduction of the membrane fluidity of human breast cancer cells by tamoxifen and 17β-estradiol J Natl Cancer Inst 82 1990 1702 1705
22. F. Severcan, N. Kazanci, F. Zorlu Tamoxifen increases membrane fluidity at high concentrations Biosci Rep 20 2000 177 184
23. R.J. Pietras, C.M. Szego Estrogen receptors in uterine plasma membrane J Steroid Biochem 11 1979 1471 1483
24. S. Matsuda, Y. Kadowaki, M. Ichino, T. Akiyama, K. Toyoshima, T. Yamamoto 17β-Estradiol mimics ligand activity of the c-erbB2 protooncogene product Proc Natl Acad Sci USA 90 1993 10803 10807
25. P.G. Mermelstein, J.B. Becker, D.J. Surmeier Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor J Neurosci 16 1996 595 604
26. G.M. Jacobsohn, E.T. Siegel, M.K. Jacobsohn 17β-estradiol transport and metabolism in human red cell blood cells J Clin Endocrinol Metab 40 1975 177 185
27. G.A. Puca, V. Sica Identification of specific high affinity sites for the estradiol receptor in the erythrocyte cytoskeleton Biochem Biophys Res Commus 103 1981 682 689
28. M.E. Mendelsohn, R.H. Karas The protective effects of estrogen on the cardiovascular system N Engl J Med 340 1999 1801 1811
29. B.C. Jubelin, J.L. Gierman Erythrocytes may synthesize their own nitric oxide Am J Hypertens 9 1996 1214 1219
30. G.A. Figtree, C.M. Webb, P. Collins Tamoxifen acutely relaxes coronary arteries by an endothelium-, nitric oxide, and estrogen receptor-dependent mechanism J Pharmacol Exp Ther 295 2000 519 523
31. K. Otsuka, P.J. Feustel, A.A. Mongin, B.I. Tranmer, H.K. Kimelberg Tamoxifen inhibits nitrotyrosine formation after reversible middle cerebral artery occlusion in the rat J Neurochem 76 2001 1842 1850
32. K. Tsuda, Y. Kinoshita, I. Nishio, Y. Masuyama Adrenomedullin and membrane fluidity of erythrocytes in mild essential hypertension J Hypertens 17 1999 201 210
33. K. Shiraishi, S. Matsuzaki, H. Ishida, H. Nakazawa Impaired erythrocyte deformability and membrane fluidity in alcoholic liver disease participation in disturbed hepatic microcirculation Alcohol Alcohol Suppl 1A 1993 59 64